Approvals/TGA/SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial

Approved

STANDARD

SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial

Moderna Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: b461b117f596ba86
Product Name: SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial
Artg Id: 370599
Artg Name: SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial
Sponsor: Moderna Australia Pty Ltd
Company Detail Path: /organization/moderna-australia-pty-ltd
Artg Date: 2021-08-09
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2021-PI-01968-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

b461b117f596ba86

Type

Standard